Publication details
Glutamic acid decarboxylase autoantibody (GADA) testing: association with clinical characteristics, beta cell function and cardio-metabolic risk factors in T1D and LADA
| Authors | |
|---|---|
| Year of publication | 2011 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation | |
| Description | HLA–DRB1 genotype. The presence of elevated GADA identifies patients unequivocally suitable for early insulin therapy. Our observations and experiences confirm that GADA can be found increased after more than 10-20 years duration of DM, although in decreasing trend. |